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Within lymph nodes, non-hematopoietic stromal cells organize and interact with leukocytes
in an immunologically important manner. In addition to organizingT and B cell segregation
and expressing lymphocyte survival factors, several recent studies have shown that lymph
node stromal cells shape the naïveT cell repertoire, expressing self-antigens which delete
self-reactiveT cells in a unique and non-redundant fashion. A fundamental role in peripheral
tolerance, in addition to an otherwise extensive functional portfolio, necessitates closer
study of lymph node stromal cell subsets using modern immunological techniques; how-
ever this has not routinely been possible in the ﬁeld, due to difﬁculties reproducibly isolating
these rare subsets.Techniques were therefore developed for successful ex vivo and in vitro
manipulation and characterization of lymph node stroma. Here we discuss and validate
these techniques in mice and humans, and apply them to address several unanswered
questions regarding lymph node composition. We explored the steady-state stromal com-
position of lymph nodes isolated from mice and humans, and found that marginal reticular
cells and lymphatic endothelial cells required lymphocytes for their normal maturation in
mice. We also report alterations in the proportion and number of ﬁbroblastic reticular cells
(FRCs) between skin-draining and mesenteric lymph nodes. Similarly, transcriptional pro-
ﬁling of FRCs revealed changes in cytokine production from these sites. Together, these
methods permit highly reproducible stromal cell isolation, sorting, and culture.
Keywords: stromal cells, lymph node stromal cells, fibroblastic reticular cells, endothelial cells, tolerance, human
lymph nodes, mouse lymph nodes
INTRODUCTION
Lymph nodes are important secondary lymphoid organs located
at lymphatic intersections in the body, allowing efﬁcient inter-
action between antigen-presenting cells and naïve T and B cells
and promoting effective initiation of immune responses (Warnock
et al., 1998; Mebius, 2003; Katakai et al., 2004a,b; Sixt et al., 2005;
Bajenoff et al., 2006; Junt et al., 2008). Lymph node stromal cells
also play a crucial and arguably underappreciated role in promot-
ing the maintenance of naïve T cells (Link et al., 2007) and the
deletion of autoreactive T cells (Lee et al., 2007; Nichols et al.,
2007; Gardner et al., 2008; Magnusson et al., 2008; Cohen et al.,
2010; Fletcher et al., 2010).
The structure of the lymph node consists of afferent lymphat-
ics emptying their contents into an “antigen sampling” subcap-
sular zone (Junt et al., 2008), which meets paracortical B cell
follicles surrounding a central cortical T cell zone, in turn lead-
ing to a largely macrophage-ﬁlled medulla at the lymph node’s
efferent face (Mebius, 2003; Willard-Mack, 2006). A conduit net-
work of microchannels also expedites delivery of small proteins
and antigens from subcapsule to deep cortex (Sixt et al., 2005).
Distinct stromal subtypes impose this structure and maintain each
microniche (Bajenoff et al., 2006).
T cell zone ﬁbroblastic reticular cells (FRCs) express
chemokines CCL19 and CCL21 to attract T cells and dendritic
cells (DCs), and lay down an intricate meshwork of collagens and
extracellular matrix on which these cells crawl (Ansel et al., 2000;
Luther et al., 2000; Katakai et al., 2004b; Bajenoff et al., 2006; Link
et al., 2007; Woolf et al., 2007). Analogous to FRCs but special-
ized for B cell attraction, follicular dendritic cells (FDCs) are a
rare stromal subset specialized for B cell attraction and antigen
presentation. FDCs are only found within B cell follicles, which
they create through CXCL13 secretion (Cyster et al., 2000). The
lymph node capsule is essentially an enlarged lymphatic vessel
constructed from lymphatic endothelial cells (LECs), which carry
interstitial ﬂuid to the node and empty it into the parenchyma.
It ﬁlters through the paracortex and cortex, eventually reaching
efferent lymphatics in the medulla, which convey lymph further
upstream (Mebius, 2003; Willard-Mack, 2006). Blood endothe-
lial cells (BECs) construct cortical blood vessels and capillaries,
including high endothelial venules specialized to attract naïve T
cells from the bloodstream (Mebius, 2003; Willard-Mack, 2006).
Several other stromal subsets have been reported in the litera-
ture but are poorly studied,with their lineages andmajor functions
undeﬁned (reviewed by Fletcher et al., 2011). Marginal reticular
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cells (MRCs) are a subset of CXCL13-producing stroma grow-
ing at the cortical face of the subcapsular sinus (Katakai et al.,
2008). Their origin is unknown though the cells show similar-
ities to FRCs, including podoplanin expression (Katakai et al.,
2008). In the spleen, an analogous stromal subset is important
for migration of immature B cells into follicles (Ansel et al., 2000).
It is hypothesized that MRCs represent the postnatal equivalent
of the lymphoid tissue organizer (LTo) subset (Katakai et al.,
2008) which is responsible for lymph node organogenesis (Coles
et al., 2010). Indeed, it has been convincingly shown that post-
natal podoplanin+ splenic stroma are capable of regenerating
through interaction with hematopoietic lymphoid tissue inducer
cells (Scandella et al., 2008).
Very little is known about medullary lymph node stroma (Eike-
lenboom et al., 1978; Willard-Mack, 2006). Similarly, the recently
described “double negative” (DN) stromal subset has been iden-
tiﬁed using ﬂow cytometry, but its function and location within
the lymph node are unknown (Cohen et al., 2010; Fletcher et al.,
2010).
Recent advances have shown that lymph node stroma play an
important role in self-tolerance induction (Lee et al., 2007;Nichols
et al., 2007; Gardner et al., 2008; Magnusson et al., 2008; Cohen
et al., 2010; Fletcher et al., 2010). FRCs (Fletcher et al., 2010)
and LECs (Cohen et al., 2010), in particular, express an array
of self-antigens from diverse tissues and organs and are capa-
ble of deleting naïve CD8 T cells with high efﬁciency if they are
autoreactive to these proteins. Any role in tolerizing CD4 T cells is
unreported, and the major driving mechanisms are unknown.
Traditionally, studies of lymph node stromal cells have relied
heavily on tissue sections and microscopy. However, our under-
standing of the roles that lymph node stroma play in maintaining
immunity has dramatically expanded in recent years, and the ﬁeld
has begun to require puriﬁcation of lymph node stromal subsets
for more sophisticated explorations of their biology. Isolation of
stromal cells provides greater challenges than isolation of leuko-
cyte populations, requiring different techniques and reagents.
Well-established methods such as cell sorting remain challenging
to most laboratories when applied to these rare stromal popula-
tions, for reasons including cell size, sorting pressure, and purity.
The stroma must be isolated using a combination of enzymatic
digestion and careful agitation to disrupt extracellular matrix and
cell–cell contacts. The cells are sensitive to both over-exposure to
enzymes and over-agitation; speed and technique are each critical
requirements for success. For these reasons, stromal cell isolation
skills have thus far been limited to very few laboratories. How-
ever, once successfully isolated, we have found FRCs and LECs
in particular to be very pliable across a range of immunological
assays.
We have reﬁned and applied a comprehensive suite of tech-
niques for the study of lymph node stroma. Surprisingly, we
found that skin-draining and mesenteric lymph nodes vary sig-
niﬁcantly in stromal composition, and that, unlike thymic stroma,
most lymph node stromal cell subsets do not require lympho-
cytic cross-talk to develop and expand or to survive in culture.
Moreover, human lymph node stroma were markedly similar
to murine stroma both in composition and amenability to cell
culture.
MATERIALS AND METHODS
MICE
Male C57Bl/6 mice aged 4–6week were obtained from the Jackson
Laboratory. Mice used for ImmGen sorting were precisely age-
matched to 6weeks. Male C57BL/6 Rag−/− mice were obtained
from Taconic. All mice were rested for 5 days post-transport, and
were speciﬁc pathogen free and cared for in accordance with insti-
tutional and National Institutes of Health guidelines. Experimen-
tal procedures were conduced with the approval of the Research
Animal Care subcommittee at the Dana–Farber Cancer Institute.
HUMAN LYMPH NODES
Human lymph nodes were procured from cadaveric donors
through the National Disease Research Interchange (NDRI)
resource center (Philadelphia, USA). Intact lymph nodes were
transported in DMEM on ice, and processed for ﬂow cytometry
or cell culture within 24 h.
ANTIBODIES
For ﬂow cytometry, cell sorting and cryosection staining of mouse
lymph node stroma, the following antibodies were used: anti-
CD45 (clone 40-F11, BD Biosciences), anti-podoplanin (clone
8.1.1,Developmental StudiesHybridomaBank),anti-CD31 (clone
MEC13.3, Biolegend), anti-Lyve-1 (clone 10.1.1, a kind gift from
Dr. Andrew Farr), and anti-MadCAM (clone MECA-367, eBio-
science). Propidium iodide and clone TER119 (Biolegend) were
used where appropriate to exclude dead cells and erythrocytes.
For staining human cells, antibodies used were: anti-CD45 (clone
HI30, Biolegend), anti-CD31 (clone WM59, BD Biosciences), and
anti-podoplanin (clone NZ-1,AngioBio Co), detected with highly
cross-adsorbed anti-rat IgG (H+ L) Alexa-488 (Invitrogen).
ENZYMATIC DIGESTION OF LYMPH NODES FROM INDIVIDUAL MICE
For ﬂow cytometric analysis or cell culture, lymph nodes from
individual mice were dissected, pierced once with ﬁne forceps,
and placed in 5ml of RPMI-1640 on ice. Where use of skin-
draining lymph nodes was speciﬁed,we dissected axillary, brachial
and inguinal lymph nodes. After all lymph nodes were dis-
sected, RPMI-1640 was removed and replaced with 2ml of freshly
made enzymemix comprised of RPMI-1640 containing 0.8mg/ml
Dispase and 0.2mg/ml Collagenase P (both from Roche), and
0.1mg/ml DNase I (Invitrogen). Tubes were incubated at 37˚C
in a waterbath and gently inverted at 5min intervals to ensure the
contents were well-mixed. After 20min, lymph nodes were very
gently aspirated and expirated using a 1-ml pipette, which dis-
rupted the capsule and released most leukocytes. The mixture was
replaced in the waterbath and large fragments were allowed to set-
tle for 30 s, after which the enzyme mix was removed and added
to 10ml of ice-cold FACS buffer (2% FCS, 5mM EDTA in PBS)
and centrifuged (300 g, 4min, 4˚C). Two milliliter of fresh enzyme
mix was added to the digestion tube, the contents gently mixed
using a 1-ml pipette, and incubated, with regular gentle mixing
using a 1-ml pipette. After 10min, the cells were mixed vigor-
ously for 30 s using a 1-ml pipette. Fragments were again allowed
to settle, the supernatant was removed and added to the previ-
ously spun cell pellet, and 2ml of fresh enzyme mix was added to
the digestion tube. From here, the digestion mix was vigorously
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mixed using a 1-ml pipette every 5min until, when held up to
light, it was clear that all remaining lymph node fragments were
completely digested. This procedure, from the time of ﬁrst incuba-
tion to complete digestion, usually took 50min, and never longer
than 60min. Supernatants were centrifuged after each removal
(300 g, 4min, 4˚C) until ﬁnally, each collection tube contained the
entire cellular contents of an individual mouse’s harvested lymph
nodes. Cells were ﬁltered through 80 μm nylon mesh, counted
using a hemocytometer, and assessed for viability using trypan
blue. Viability exceeded 95%. The 5× 106 cells per stain were then
incubated with 50μl diluted antibodies for 20min at 4˚C in ice-
cold FACS buffer (2%FCS,5mMEDTA in PBS) before acquisition
on a FACSCalibur or FACSAria IIu (BD Biosciences).
ENZYMATIC DIGESTION AND STROMAL ENRICHMENT OF LYMPH
NODES FROM POOLED MICE FOR CELL SORTING AND LARGE-SCALE
ISOLATION
Digestion of multiple pooled mice generally proceeded as
described in Section “Enzymatic Digestion of Lymph Nodes From
Individual Mice,” with changes as follows (depicted graphically
in Figure 1): lymph nodes from 4 to 10 mice were pooled in a
single tube and digested using 5ml of enzyme mix per digestion
step. After lymph nodes were fully digested, and the cells cen-
trifuged and counted, the single cell preparation was enriched for
non-hematopoietic stromal cells using CD45 microbeads and the
autoMACS system (both from Miltenyi). We used 7 μl beads per
107 cells, incubated in FACS buffer for 20min on a rotating wheel
at 4˚C. The labeled fraction was then depleted using the Depletes
program, according to the manufacturer’s instructions. Enriched
stroma were then counted and stained using a high volume of
antibody (100μl of diluted antibody cocktail per 106 cells) for
cell sorting.
ENZYMATIC DIGESTION OF HUMAN LYMPH NODES
Human lymph nodes were carefully cleaned of fat and connective
tissue, then cut into small pieces (<0.5 cm) using ﬁne scissors.
Digestion proceeded according to Section “Enzymatic Digestion
of Lymph Nodes From Individual Mice,”however enzyme concen-
trationwas increased to 2.4mg/mlDispase and 0.6mg/mlCollage-
nase P (both from Roche), and 0.3mg/ml DNase I (Invitrogen) in
RPMI-1640. In some cases we did not digest the entire organ, and
instead took a random selection of approx. 20 mixed fragments,
representing all areas of the node. After 60min, lymph node frag-
ments were completely digested, and were then ﬁltered, counted
and where required stained, as detailed in Section “Enzymatic
Digestion of Lymph Nodes From Individual Mice.”
LOW-PRESSURE FLOW CYTOMETRIC STROMAL CELL SORTING
Flow cytometric sorting of stromal cells is improved when a
specialized low pressure, large aperture setup is used; however
there are technical challenges inherent in resetting a sorter to a
non-standard speciﬁcation and then successfully sortingpurepop-
ulations. We used FACSAria or upgraded FACSAria IIu machines
utilizing FACSDiva software (all from BD Bioscience) set to 20 psi
and ﬁtted with a 100μm tip. While each machine will differ, we
have found that the following approximate speciﬁcations have
applied to at least four different FACSAria machines set up for
stromal sorting. These differ from the suggested setups speciﬁed
by the manufacturer.
Decreased stream pressure increases droplet size, such that only
5–6 droplets are visible through the stream visualization window
at 20 psi, instead of 10–12 droplets at 70 psi. While the droplet
breakoff point directly affects sort success and should always be
visible, it is possible for the satellite resolution point to occur below
viewwhile sorting at low pressure, even after increasing the droplet
frequency. This does not preclude a successful sort; however, it is
important to be conﬁdent that satellite resolution occurs no more
than one to two droplets below the screen. This can be reasonably
established in two ways: ﬁrst, by temporarily adjusting the droplet
breakoff point higher and out of view, so that the satellite resolu-
tion point becomes visible, and counting the number of droplets
between breakoff and resolution before readjusting downwards;
and second, by looking at the decreasing distance between satellite
and droplet, and estimating the number of droplets until resolu-
tion occurs. The satellites, if not resolved on-screen, should be very
close to resolution.
Critically, deciding whether to apply the attenuation control
(which dampens droplet amplitude) alters subsequent speciﬁ-
cations considerably. Sample setup sort reports both with and
without attenuation are provided for reference (Table 1). BD
FIGURE 1 | Schematic diagram of pooled murine lymph node stromal
cell digestion and preparation for cell sorting. 1. Add enzyme mix
(RPMI-1640 with 0.8mg/ml Dispase, 0.2mg/ml Collagenase P, 0.1mg/ml
DNase I) to tissue, incubate in 37˚C waterbath. 2. After 10–20min (see
Materials and Methods), agitate lymph node fragments using 1ml pipette,
then incubate until the fragments settle. 3. Remove the supernatant
containing released cells, centrifuge it and store it on ice. 4. Repeat steps 1–3
until all fragments are fully digested (no more than 60min). 5. Pool all
supernatant fractions, centrifuge, ﬁlter, and count. 6. Add anti-CD45
microbeads, incubate at 4˚C on rotating wheel. 7. Use MACS or AutoMACS to
deplete CD45+ cells, count. 8. Stain enriched CD45− stroma with antibodies;
sort to high purity using 100μm tip at 20 psi.
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Table 1 | A sample range of low-pressure stromal sorting parameters
for 100μm tip in the FACSAria and FACSAria IIu (BD Biosciences).
n=4–8 independent experiments.
Sort parameter FACSAria FACSAria IIu
Frequency 23.1–25.9 19.2–21.6
Amplitude 24.0–45.6 8.6–13.5
Phase 0–3 0
Attenuation On Off
Drop delay 18.56–20.81 15.96–17.92
First drop 189–295 200–243
Target gap 6–10 10
Biosciences manual recommends attenuation not be applied when
sorting at 20 psi; however, we found it necessary at times with the
FACSAria (but not FACSAria IIu) to generate a good stream.While
a manual adjustment of the 100μm tip was required to generate
a good stream using the FACSAria, we have not had to move the
tip or utilize attenuation for the FACSAria IIu system, where the
o-ring is permanently ﬁtted.
Lastly, we have noted that the 633-nm laser delay can sud-
denly change when low pressure is engaged. The reasons for this
are unclear, but we recommend using CST beads to set delays, or
testing laser function using SPHERO Rainbow particles (BD Bio-
science; or any similar calibration check). Note that a lack of signal
from the 633-nm lasermay require re-calibration of the laser delay.
Compensation for a stromal cell sort should be strictly per-
formed using enriched stromal cells. Stroma are large cells with
a degree of accompanying autoﬂuorescence. A machine compen-
sated using leukocytes yields suboptimal resolution of populations
when stroma are sorted. Enriched stroma should be used to com-
pensate, because in unenriched populations, stroma are usually
rare, and we ﬁnd that the autocompensation software cannot dif-
ferentiate between normal levels of autoﬂuorescence in a digested
single cell suspension and true stromal staining.
When the machines are optimally calibrated, sorting proceeds
with excellent resolution of sorting streams and good efﬁciency.
Sort streams should resolve well as bright, discrete dots in the sort
window; “spraying” of the sorting streams should not be evident.
AutoMACS-enriched stroma were routinely sorted to high
purity (>95%) into TRIzol (Invitrogen). After gating on
CD45− propidium iodide− stroma, subsets were sorted as fol-
lows: FRCs, podoplanin+CD31−; LECs, podoplanin+CD31−;
BECs, podoplanin−CD31+; double negative stromal cells (DNs),
podoplanin−CD31−.
MICROARRAY ASSAYS AND ANALYSIS
RNA from 10,000 to 15,000 sorted cells was isolated as previously
described (Yamagata et al., 2004), then ampliﬁed and hybridized
to Affymetrix GeneChip Mouse Gene 1.0 ST Arrays (Santa Clara,
CA, USA) using the GeneChip Whole Transcript Sense Target
Labeling Assay according to the manufacturer’s instructions. This
yielded whole-transcript information using probes designed to
bind in multiple locations across each gene. Raw data was normal-
ized using the robust multi-array average (RMA) preprocessing
algorithm (performing background adjustment, quantile normal-
ization, and summarization; Irizarry et al., 2003), in the Expression
File Creator module of GenePattern. Probe lists were analyzed for
expression in at least one subset (excluded if mean expression value
<120 across all subsets), and for low variance among replicates
(excluded if coefﬁcient of variation >0.5 in either population).
We used the Multiplot module of GenePattern to calculate dif-
ferences between skin lymph node FRCs and mesenteric lymph
node FRCs. Differences were considered for further analysis if
the fold-change in expression was >2 and P< 0.05 (Student’s T -
test). Output data lists were ranked using Microsoft Excel, and
gene lists were analyzed for enrichment across KEGG pathways
using the DAVID program’s Functional Annotation tool (NIAID,
david.abcc.ncifcrf.gov; Dennis et al., 2003), and with Affymetrix
exon background set to the MoGene-1_0-st-v-1 chip. KEGG path-
way analyses with T -test P-values< 0.05 after multiple hypothesis
(Benjamini) correction were considered signiﬁcant. The NCBI
GEO accession number for the data series is GSE15907.
LYMPH NODE STROMAL CELL CULTURE TECHNIQUES
Lymph nodes were digested as detailed above, then counted, and
plated at a concentration of 5× 105 cells/cm2. Cell culture media
was αMEM supplemented with 10% batch-tested, low Ig FCS,
and 1% Penicillin/Streptomycin. Plates were washed after 24 h
to remove non-adherent cells. After 5 days, mouse cell cultures
primarily contained LECs and FRCs. Human cell cultures grew
more slowly and were harvested after 7 days. Human lymph node
stromal cell cultures primarily contained FRCs and DNs. A non-
standard harvesting protocol was routinely utilized, consisting of a
short incubation in low-concentrationTrypsinwith EDTA tomin-
imize trypsin-based shearing of important cell surface markers
(Table 2). Cells were washed with PBS to remove residual protein,
Table 2 | Enzyme sensitivity of surface markers used to characterize
non-hematopoietic lymph node stromal cells.
Surface marker Collagenase P Dispase Trypsin
CD31 + + −
CD40 + + ±
CD44 + + +
CD45 + + +
CD80 + + −
CD140a + + −
ICAM-1 + + +
Gp38 + + +
Thy-1 + + ±
PD-L1 + + +
Sca-1 + + +
Lyve-1 + + +
VCAM-1 + + +
MadCAM + + +
Cultured or freshly isolated stromawere incubated with enzymes for 10min, then
surface protein expression tested by ﬂow cytometry. Data represent n=3 inde-
pendent experiments. + Surface marker present, − Surface marker absent, ±
Surface marker partially cleaved.
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and harvest buffer (0.2% Trypsin with 5mM EDTA in PBS) was
added to culture plates. Cells were incubated in harvest buffer at
37˚C for 2min. At this point, their morphology became rounder,
and an equal volume of complete media was immediately added
to wells. Cells were washed from the plate with gentle agitation
using a 1-ml pipette, and supernatant was added to another equal
volume of complete media for centrifuging (300 g, 3min, 4˚C).
FRCs and LECs were replated, sorted, or MACS-puriﬁed from this
preparation as required.
For three-dimensional (3D) cultures and network analyses,
cells were cultured in deformable matrices constructed from
3.2mg/ml of high concentration rat tail Collagen I (BD Bio-
sciences), 1.8mg/ml Matrigel basement membrane matrix (BD
Bioscience), 8.3% (v/v) of 5× αMEM stock made in-house from
αMEM powder (Invitrogen), and 30% (v/v) culture media con-
taining cells to be plated. Gel components were mixed on ice and
200μl plated onto plastic, or glass-bottomed culture dishes for
imaging (MatTek). Gels were left to set at 37˚C for 10min before
being coveredwith culturemedia. For contraction assays, gels were
created in ﬂat-bottomed 96 well culture plates and photographed
after 15 h. Contraction was measured using the following equa-
tion: area contracted gel (cm2)/area well (cm2) ∗100=% contrac-
tion. For time-lapse live cell imaging, bone-marrow derived DCs
or B cells were mixed at a 5:1 ratio with puriﬁed cultured FRCs.
During imaging, gels were incubated at 37˚C with 10% CO2 in
αMEM containing 10% FCS. Movies depict time-lapse imaging
with 1 frame acquired every 90 s.
IMMUNOHISTOLOGY AND CONFOCAL MICROSCOPY
Lymph nodes were freshly dissected and ﬁxed in 10%
paraformaldehyde for 4 h, then left in 10% sucrose solution
overnight. Blockswere then embedded inOCT compound (VWR)
and snap-frozen, then stored at −80˚C. Lymph nodes were
cryosectioned (7μm) using a Leica cryostat, and acetone ﬁxed,
then blocked for 30min using 2% BSA. After washing in PBS,
sections were stained with primary antibody for 60min, then
washed and stained with secondary antibody for a further 60min.
Slides were mounted with a coverslip using ﬂuorescent mounting
medium (DAKO) and stored at 4˚C. Images were acquired using a
Leica Sp5 confocal microscope.
STATISTICAL ANALYSIS
GenePattern’s Multiplot program was used to calculate T -test P-
values on normalized, array data where the coefﬁcient of variance
between replicates for any sample was <0.5. A P-value of <0.05
was considered signiﬁcant if the fold-change observedwas also<2.
Genes were tested for KEGG pathway association using the DAVID
program (david.abcc.ncifcrf.gov), which compared data using a
modiﬁed Fisher’s Exact Test, and a T -test with a Benjamini multi-
ple hypothesis correction, to show enrichment of two or more
genes in a particular list. The non-parametric Mann–Whitney
U -test was used to compare ﬂow cytometric data (Prism).
RESULTS
ENZYMATIC ISOLATION OF MOUSE AND HUMAN LYMPH NODE
STROMAL CELLS
The studyof lymphnode stromal cells has gathered recentmomen-
tum, with several high-impact papers dissecting their newly dis-
covered roles in maintaining (Link et al., 2007) and deleting (Lee
et al., 2007; Nichols et al., 2007; Gardner et al., 2008; Magnusson
et al., 2008; Yip et al., 2009; Cohen et al., 2010; Fletcher et al., 2010)
naïve T cells. Methodological capabilities, however, have been a
limiting factor.
We therefore aimed to develop a low-mortality enzymatic
digestion protocol which would enable highly reproducible iso-
lation of lymph node stromal cells with low variability. Using a
combination of enzymatic and physical dissociation (Figure 1),we
routinely isolated stromal cells with >95% viability (Figure 2A)
using trypan blue on whole lymph node suspensions (1.5%
stroma) immediately after isolation. Six hours after isolation and
stromal enrichment, the average viability of stroma using pro-
pidium iodide was 87.8± 0.8% (mean± SD, n = 3 experiments).
This high viability also allowed us to characterize and compare
the number of each stromal subset present in individual mice, and
was a key factor in successfully sorting and culturing these cells.
We used CD45, podoplanin, CD31, and MadCAM (Figure 2B) to
study ﬁve major subsets of lymph node stroma. The MadCAM+
MRC subset, in particular, has not previously been isolated for
ﬂow cytometric analysis.
We ﬁrst directly compared our ﬂow cytometric strategies to
previously deﬁned in situ histological analyses of stromal subsets
(Figure 2C). Our aim was to establish methods that would enable
changes in stromal architecture to be monitored in parallel with
changes to number or proportion of cell types,mRNA proﬁle, and
other techniques requiring cell isolation.
Accordingly, we found that FRCs, as deﬁned by ﬂow cytom-
etry, created a reticular network throughout the T cell zone as
expected (top panel). BECs expressed CD31 but not podoplanin
and were primarily present in the cortex (top panel), with high
endothelial venules distinguishable by their small size and cuboidal
morphology. LECs, deﬁned by coexpression of podoplanin and
CD31, lined large lymphatic vessels in the hilar region of
the medulla (middle panel) and subcapsule (data not shown).
This hilar region also contained large blood vessels (CD31+
podoplanin−). MadCAM+ reticular cells lined the subcapsule
(bottom panel) and MadCAM staining was also present in the
B cell zone, as previously reported. We found that subcapsu-
lar LECs (shown here expressing Lyve-1) also expressed Mad-
CAM (bottom panel), making the subcapsule a MadCAM-rich
region of the lymph node. Phenotypically, MRCs formed a sub-
set within the podoplanin+ CD31− FRC gate by ﬂow cytometry
(Figure 2B).
Wehypothesized that our isolationmethods could be applied to
isolate human lymph node stroma, allowing the creation of useful
ex vivo experimental systems. Human lymph node stromal archi-
tecture is well described by histology (Link et al., 2011) but subsets
have not been isolated for ﬂow cytometry or other immunological
studies. It is unknown whether human lymph node stromal cells
maintain naive T cells or tolerize autoreactive T cells as murine
lymph node stromal cells do.
We acquired human lymph nodes of non-mesenteric origin
fromcadaveric donors.While increased enzyme concentrationwas
required to digest the lymph nodes (see Materials and Methods),
once digested, their stromal composition was markedly similar to
mice (compare Figures 2B,D). These results suggest that murine
lymph node stromal cell techniques may be equally applicable to
human studies.
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FIGURE 2 |Validation of a low-mortality method for isolation of lymph
node stromal subsets. (A) Viability of single cell suspensions prepared using
a low-mortality enzymatic digestion method. n=6, mean+SD. (B)Typical
ﬂow cytometric proﬁles of lymph node stromal subsets freshly isolated from
skin-draining or mesenteric lymph nodes of individual mice. (C) Lymph node
stromal subsets identiﬁed in situ on cryosections. Top panel: T cell zone FRCs
(podoplanin+ CD31−) and high endothelial venules (podoplanin−CD31+ with
cuboidal morphology). Two examples of HEVs are designated using arrows.
Middle panel: medullary LECs (podoplanin+CD31+) and large medullary blood
vessels (podoplanin−CD31+). Medullary lymphatic vessel/s are shown using
arrows. Bottom panel: Capsular afferent LECs (Lyve-1+ MadCAM+), MRCs
(subcapsular, Lyve-1− MadCAM+), and FDCs (follicular, Lyve-1−, MadCAM+).
Colocalization overlay shown in white on merged images. Original
magniﬁcation: 200×. (D) Human lymph nodes (non-mesenteric origin) were
digested and stained for ﬂow cytometric analysis. Dotplots are representative
of n=4 independent experiments.
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MESENTERIC LYMPH NODES CONTAIN FEWER FRCs THAN
SKIN-DRAINING LYMPH NODES
To further validate our digestion, we tested its reproducibility by
assessing how much the proportional makeup of lymph node
stromal cell subsets varied between age-matched mice. We also
compared the stromal composition of skin-draining and mesen-
teric lymph nodes. While these lymph nodes have well-established
structural similarities and arewell-studied by histology, their onto-
genies occur at different times and are dependent on different sig-
naling pathways (Mebius, 2003). Additionally, mesenteric lymph
nodes are continually exposed to gut and gastromucosally derived
antigens, while skin-draining lymph nodes are not.
Surprisingly, we found that while similar numbers of cells
were isolated from each skin-draining or mesenteric lymph
node (Figure 3A), the stromal composition signiﬁcantly differed
(Figure 3B). FRCs, which grow throughout the T cell zone, were
present at greater frequency (Figures 2B and 3B), and were more
numerous (Figure 3C) in skin-draining lymph nodes than mesen-
teric lymph nodes. LECs, BECs, DNs, and MRCs were present at
similar numbers in both sites (Figure 3C), making the difference
FRC-speciﬁc.
We asked whether this difference was due to skewing in the
proportions of the MRC subset (Katakai et al., 2008) which, we
found, falls within the FRC gate (Figure 2B). About 10–20% of
cells within the FRC gate expressed MadCAM in 5week old male
mice, with a higher proportion in mesenteric lymph nodes than
skin-draining lymph nodes (Figures 2B and 3D). However, while
MRC proportions were signiﬁcantly altered between sites, similar
to LECs, their overall numbers were not (Figure 3E). This suggests
that MRC numbers and FRC numbers are differently regulated,
since MRCs, like the other stromal subsets, are numerically similar
between sites, while FRCs are reduced in mesenteric lymph nodes.
In some lymphoid organs, such as the thymus, the numbers
of predominant stromal cell subsets expand or shrink in parallel
with developing T cells. We tested whether this applied to the FRC
population using Rag−/− mice, which lack T and B cells. FRCs
develop in Rag−/− lymph nodes, but it is not known whether they
expand and contract in response to lymphocyte numbers. This
question is particularly relevant to infection, since lymph nodes
must expand dramatically in a short time to contain proliferating
lymphocytes.
While Rag−/− mice had smaller lymph nodes (Figure 3F), they
possessed normal numbers of FRCs compared to age-matched
wildtype controls (Figure 3G). The number of LECs, however,
was signiﬁcantly reduced, suggesting that their numerical home-
ostasis is linked to the presence of mature lymphocytes. Rag−/−
FRCs did not differ from WT in rates of cell turnover (data not
shown), and after injecting LPS into mice, the number of FRCs did
not expand alongside T and B cells (data not shown). FRC num-
bers were therefore maintained completely independent of mature
lymphocytes under lymphopenic, steady-state, and inﬂammatory
conditions.
Surprisingly, we found that the MRC subset was underde-
veloped in Rag−/− mice (Figures 3H–J). It is reported that
MadCAM+ MRCs exist by histology inRag−/− mice (Katakai et al.,
2008), but in our hands, both the numbers of MadCAM+ MRCs
and the amount of MadCAM protein per MRC were signiﬁcantly
reduced (Figures 3H–J). This also applied to MadCAM+ LECs
(Figures 3H–J), suggesting that upregulation of MadCAM expres-
sion in both cell types denotes a developmental stage requiring the
presence of lymphocytes, though expression of the protein itself
can occur in their absence. While the proportion of MadCAM+
LECs was similar between WT and Rag−/− (Figure 3H), the sig-
niﬁcant reduction in total LECs (Figure 3G) translated to reduced
numbers of MadCAM+ LECs (Figure 3I).
ENRICHING AND SORTING LYMPH NODE STROMAL CELL SUBSETS
Following the successful digestion of lymph nodes, we next
adapted the means to successfully sort and culture the stromal
cells. Sorting stromal cells can be technically difﬁcult (seeMaterials
and Methods) and we used MACS-based depletion of hematopoi-
etic cells to decrease sorting times and increase the resulting purity.
This additional step yieldedminimal loss of stroma (Figures 4A,B)
and did not appreciably alter the stromal composition; we saw no
selective loss of stromal subsets post-MACS (Figure 4C) and, after
sorting, achieved excellent purity (Figure 4D).
Using this method, we sorted FRCs from skin-draining and
mesenteric lymph nodes as part of the multicenter ImmGen Con-
sortium (www.immgen.org). This involved transcriptomic analy-
sis of cells sorted under highly controlled, minimally variable
conditions, with the overall aim of generating a public data-
base to provide a comprehensive, cross-referenced map of the
immunological genome.
Fibroblastic reticular cells from skin-draining and mesenteric
lymph nodes were analyzed for expression of 25,194 probes to
yield a list of 11,162 probes expressed above an arbitrary threshold
(mean expression value >120) in either skin-draining or mesen-
teric lymph nodes. These probes were also ﬁltered for a low (<0.5)
coefﬁcient of variance between replicates.
We ﬁrst conﬁrmed that FRCs from these different locations
shared expression of previously published FRC-speciﬁc markers
such as CD140a, CCL19, and IL7 (data not shown), then analyzed
the data for differences. Comparing skin-draining versus mesen-
teric lymph node FRCs, a volcano plot depicting fold-change
and P-value showed that 130 probes were signiﬁcantly upregu-
lated in FRCs from skin-draining compared to mesenteric lymph
nodes, while expression of 97 probes was signiﬁcantly higher in
mesenteric lymph node FRCs compared to skin-draining (>2-
fold-change, P < 0.05; Figure 5A). After mapping the probes to
unique genes, these data corresponded to upregulation of 126
genes in skin-draining lymph node FRCs (Table S1 in Supple-
mentary Material) and 54 genes in mesenteric lymph node FRCs
(Table S2 in Supplementary Material).
We were interested in whether these lists contained evidence
for activation of particular gene pathways, or gene networks
uniquely operating in either cell type, as a clue to any site-
speciﬁc specialization. Using the free online program DAVID
(version 6.7; National Institute of Allergy and Infectious Dis-
eases), we used a network analysis tool (KEGG) to comb the
lists for known biological connections between these genes, then
used statistical analysis tools to assess whether the connected
genes appeared together at a frequency greater than would be
expected by chance. The KEGG pathway mmu04060,which covers
cytokine–cytokine receptor interaction, was signiﬁcantly enriched
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FIGURE 3 | Lymph nodes show site-specific alterations in stromal
composition. Lymph nodes from individual C57Bl/6 mice were digested
and stained for ﬂow cytometry. (A) Lymph node cellularity. (B) Proportion
of CD45 negative lymph node stromal subsets. (C) Number of lymph node
stromal subsets. (D) MadCAM+ cells shown as a proportion of total FRCs
or LECs. (E)Total number of MadCAM+ FRCs or LECs. (F) Cellularity of
skin-draining lymph nodes isolated from age-matched Rag−/− or WT (B6)
mice. (G) Number of lymph node stroma from age-matched Rag−/− or WT
mice. (H)The proportion, or (I) number of MadCAM+ FRCs (MRCs) or
LECs in SLN of age-matched Rag−/− or WT mice. Plots are representative
of n=5 mice. (J) Mean ﬂuorescence intensity (MFI) of MadCAM staining
in MRCs or MadCAM+ LECs. WT, wildtype. *P<0.05; **P<0.01
Mann–Whitney U -test. n=5–10 mice from two to three independent
experiments.
in FRCs from skin-draining lymph nodes compared to mesenteric
(genes appeared at a frequency 4.8-fold higher than expected by
chance, Benjamini corrected P-value= 0.0055). This list included
10 genes of immunological relevance (Figure 5B) upregulated in
skin-draining lymph node FRCs by at least twofold. Genes upreg-
ulated in mesenteric lymph nodes were not signiﬁcantly enriched
in an identiﬁable KEGG pathway, but notably included genes
involved in regulating the growth of ﬁbroblasts, genes relevant
to the gut microenvironment, such as those involved in retinoic
acid metabolism or MadCAM expression, endothelial cell cross-
talk, extracellular matrix secretion, and outgrowth of peripheral
neurons (Table 3).
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FIGURE 4 | Lymph node stromal cell enrichment and sorting. (A)
Skin-draining lymph nodes from 6 to 10 C57Bl/6 mice were enzymatically
digested and enriched for CD45− stromal cells using autoMACS. The
number of CD45− stroma added to the column (input) and retrieved from
the column (output) were charted. Data depict n=5 independent
experiments. (B) Percent stromal cell yield for autoMACS enrichment of
stroma was calculated. (C) Flow cytometric proﬁles of stromal cells pre-
and post-autoMACS enrichment. (D) Sorting strategy and post-sort purity
for major lymph node stromal cell subsets. Dotplots gated on CD45−
propidium iodide− stroma.
FIGURE 5 | Site-specific transcriptional upregulation of cytokines in
FRCs from skin-draining lymph nodes. (A) Microarray analysis comparing
FRCs sorted from skin-draining (SLN) or mesenteric lymph nodes (MLN).
Dotplot depicts P -value versus fold-change for SLN versus MLN for 15,486
selected probes. Probes upregulated in SLN are shown in red, while probes
upregulated in MLN are blue; (P<0.05 and fold-change>2;T -test). n=4–5
independent replicates. (B) Genes enriched in SLNs encoding cytokines
and cytokine receptors (KEGG pathway mmu04060; P<0.015; modiﬁed
Fisher’s exact test with Benjamini correction). The fold-increase in mean
expression in SLNs compared to MLNs is shown.
CULTURED FRCs MIMIC IN VIVO FUNCTION AND SUPPORT LEUKOCYTE
MIGRATION
We next tested the ability of lymph node stroma to grow in cul-
ture. We found that stroma from a successfully digested lymph
node cell suspension will readily adhere to tissue culture plates
within 2 h of plating and begin to expand at the expense of CD45+
leukocytes, which form less than 10% of the culture after 5 days
(Figure 6A). FRCs and LECs readily grew in culture, while BECs
and DN cells did not (Figure 6A). FDCs did not grow in culture
(Figure 6B). Importantly, our low trypsin, high EDTA harvesting
protocol allowed retention of important surface markers such as
CD31 (Figure 6C) and CD140a (not shown; see Table 2). We
found that 5× 105 cells/cm2, containing approx. 5× 103 stro-
mal cells, routinely yielded approx. 1.5–2 × 104 stroma/cm2 after
5 days of culture. This culture system enabled easy expansion and
manipulation of FRCs, LECs, and MRCs.
Fibroblastic reticular cells in particular became highly polar-
ized in two-dimensional (2D) culture (Figure 6D) showing strong
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Table 3 | Genes upregulated in FRCs from mesenteric lymph nodes
compared to FRCs from skin-draining lymph nodes, grouped by
functional similarity.
Functional group Gene Fold-change P -value
Regulation of cell growth in
ﬁbroblasts
Wnt2b 8.13 **
Slit2 6.06 **
Sfrp4 3.13 **
Wfdc1 2.77 **
Mest 2.60 *
Dhcr24 2.48 **
Fgfr3 2.39 **
Igfbp6 2.20 *
Figf 2.17 **
Bmp2 2.12 **
Induced by gut-speciﬁc factors Nkx2-3 5.75 **
Lrat 4.67 **
Tgm2 2.66 **
Enpp3 2.48 *
Kcnn3 2.24 *
Meis1 2.13 **
Pltp 2.07 **
Extracellular matrix or cell–cell
junction interactions
Mfap5 3.38 *
Hmcn2 2.69 **
Gpc3 2.34 **
Itih4 2.34 **
Cldn10 2.32 **
Col14a1 2.26 **
Loxl1 2.25 **
Cilp 2.01 *
Endothelial or pericyte cross-talk Ptgs1 3.17 **
Vipr2 2.92 **
Smoc2 2.79 *
Itih4 2.34 **
Npr1 2.33 *
Figf 2.17 **
Agt 2.03 **
Neuronal cross-talk Efna5 2.58 **
Gpr126 2.22 **
Tmem35 2.04 **
Ngf 2.00 **
Gene expression of sorted FRCs from skin-draining or mesenteric lymph nodes
was compared using microarray analysis. Gene selection was based on expres-
sion (mean expression of>120 in either SLN orMLN), a low coefﬁcient of variance
between replicates (<0.5), fold-change (at least twofold increased in mesen-
teric lymph node FRCs compared to skin-draining FRCs) and P-value (*<0.5;
**<0.01; Student’s T-test). Genes were grouped based on literature keyword
searches.
F-actin stress ﬁbers (Figure 6E). This did not mimic their mor-
phology in vivo; so, using an optimizedmix of Collagen I,matrigel,
and enriched αMEM, we also explored 3D culture of FRCs and
LECs, as a tool to examine their function when permitted to
expand and connect in 3Ds as they do in vivo. We found that
FRCs stretched and formed extensive networks when grown in
3D (Figures 6D,E), while LECs preferred a ﬂat surface and grew
more successfully in 2D culture (Figure 6D). Interestingly, neither
cell type grew to overconﬂuence under 3D conditions (data not
shown), suggesting an innate regulation of cell density that did
not occur in 2D culture. To validate the biological relevance of
this in vitro FRC network, we performed two experiments. First,
we placed a high number of FRCs into a small matrigel plug,
and monitored their ability to contract the gel (Figure 6F). FRCs
express high levels of alpha smooth muscle actin and are highly
contractile (Link et al., 2007). We found that FRCs contracted the
gel with high efﬁciency, and that this contraction was prevented
when the Src tyrosine kinase inhibitor PP2 was added to the gel.
Second, we added bone-marrow derived DCs or spleen-derived
lymphocytes to a gel containing FRCs, and used a live-imaging
approach to ﬁnd that, as reported in vivo, DCs and lymphocytes
crawled efﬁciently and preferentially along the FRC network (stills
are shown in Figure 6G with full time-lapse movies shown in
Movies S1 and S2 in Supplementary Material).
Using the same methods, we successfully cultured human
lymph node stromal cell subsets. Unlike murine cells, BECs and
DN cells grew in vitro alongside LECs and FRCs (Figure 6H).
Together, these results showed that murine lymph node stroma
were readily isolated for ﬂow cytometry and sorting, and could
be cultured in the absence of leukocytes, yet created extensive 3D
networks on which leukocytes would readily crawl, as reported
in vivo. Our data suggested that human lymph node stroma were
similarly amenable to study using murine techniques.
Together, these results describe the validation of a suite of
techniques applicable to the study of lymph node stromal cells
in mice and humans, under a variety of ex vivo and in vitro
conditions.
DISCUSSION
Techniques routinely employed in immunology and cell biology,
such as generating viable single cell suspensions of reproducible
composition from primary tissues, have created difﬁculties when
applied to lymph node stroma. As such, histology and whole-
organ PCR, or in vivo systems involving lymphocytic readouts
have been the ﬁeld’s standard. These have lead to several impor-
tant advances regarding the role of lymphnode stromal cell subsets
in steady-state tolerance and immunity; however, there are many
unexplored questions of direct biological and medical relevance.
We believe that modern immunological and cell biological tech-
niques, reﬁned and adapted for use with these rare and delicate
cell types, will be required to answer these.
Highlighting this unmet need, DN stroma in particular remain
almost completely undeﬁned. Several groups have now reported
the existence of this non-hematopoietic stromal cell subset (which
may or may not be homogeneous; Link et al., 2007; Cohen et al.,
2010; Fletcher et al., 2010) but despite comprising >10% of the
lymph node stromal niche and harboring an Aire-expressing cell
type (Cohen et al., 2010; Fletcher et al., 2010), it has remained
almost entirely uncharacterized. Such fundamental characteristics
as morphology, lineage, surface phenotype, and function are unre-
ported. These deﬁcits speak directly to the difﬁculties inherent in
studying lymph node stromal cells.
One such difﬁculty in studying DN cells is that dying
or poorly stained lymphocytes appear CD45-low or negative,
Frontiers in Immunology | Immunological Tolerance September 2011 | Volume 2 | Article 35 | 10
Fletcher et al. Isolating lymph node stromal cells
FIGURE 6 |Three-dimensional (3D) culture of FRCs mimics in vivo
function. (A) Lymph nodes were digested, and single cell suspensions put
into culture for 5 days, then trypsinized and stained for ﬂow cytometric
proﬁling. Stromal cells were identiﬁed using CD45 (left panel), then stained
with CD31 and podoplanin (right panel, gated on CD45− stroma). (B) Cultured
stromal cells stained for FDC-M1 or a relevant isotype control. (C) CD31
staining in cultured stromal cells harvested using a high trypsin or low trypsin
protocol. Dotplots represent n=3 independent experiments. (D) Cultured
stromal cells were harvested, then puriﬁed using autoMACS. FRCs, LECs, or
mixed FRCs and LECs were plated in 2D (plastic tissue culture plates), or 3D
(a matrigel and collagen gel) and cultured for a further 3 days prior to imaging.
Original magniﬁcation 10×. Images represent n=2 independent experiments.
(E) F-actin (red) and DAPI (green) were used to stain puriﬁed FRCs in 2D or 3D
to highlight networks. Images represent n=3 independent experiments. (F)
Puriﬁed FRCs were placed in 3D culture in a 96 well plate with or without
PP2. After 24–36 h, gel contraction was quantiﬁed. Images are representative
of n=3 independent experiments. Bar graph depicts mean+SD, P<0.05,
T -test. (G) Puriﬁed FRCs were placed in 3D cultured with puriﬁed dendritic
cells (DCs) or B cells, then images were sequentially acquired every 90 s.
Stills from Supplemental Movies 1 (DCs) and 2 (B cells) are shown (upper
panel), original magniﬁcation: 20×. Lower panel shows a cartoon of the
imaged stromal cell (gray) and the relevant migrating leukocyte (blue). (H)
Human lymph nodes were digested, and single cell suspensions put into
culture for 7 days, then trypsinized and stained for ﬂow cytometric proﬁling.
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appearing in the stromal cell gate with the same phenotype
(CD31−podoplanin−) as DN stroma. This greatly skews the pro-
portions of true stromal subsets, making it difﬁcult to tie down
even the most basic proportional composition of the lymph node
stromal niche. Indeed, since stroma comprise only 1–2% of lymph
node cells, non-viable lymphocytes routinely outnumber stroma
even in a highly viable (>95% live) single cell suspension. In
our experience, inclusion of a dead cell stain such as propidium
iodide, does not adequately remove cells that appear CD45-low
post-digestion.
For this reason, we felt that the key to reproducible isolation
of stroma lay in developing a low-mortality enzymatic digestion
protocol. Using a combination of dispase, DNase I, and collage-
nase P, we routinely isolated a high number of stromal cells with
>95% viability. This also allowed us to compare each stromal sub-
set across individualmice andhumans, and to successfully sort rare
subsets, including DN cells and MRCs,which will be the subject of
further study. It has not yet been possible to identify DN stroma by
histology, since nounique or differentially expressed surfacemark-
ers are reported. However, the sorting strategy described herein
could be used to perform the unbiased array-based approaches
required to unmask this rare subset.
Similarly, these methods allowed us to isolate the four major
populations of human lymph node stromal cells directly from
primary tissue, opening the door for sophisticated clinical and
pre-clinical studies. It is now well established that mouse lymph
node stromal cells express many clinically relevant self-antigens
and directly present these to T cells to tolerize them (Lee et al.,
2007; Nichols et al., 2007; Gardner et al., 2008; Magnusson et al.,
2008; Cohen et al., 2010; Fletcher et al., 2010). It is possible that the
same mechanisms may be at play in humans. Studies have shown
that FRCs and LECs retain the ability to present PTAs to naïve T
cells while in culture, mimicking interactions seen in vivo (Cohen
et al., 2010; Fletcher et al., 2010), though it is unclear whether this
is due to continual transcription of the PTAs in question, or reten-
tion of peptide-MHC. These techniques could be used to address
this and many other outstanding questions pertaining to human
lymph node biology.
Further, the development of 3D culture systems for lymph
nodes will allow the creation of highly controlled experimental
systems mimicking conditions and interactions in vivo. We found
that DCs and lymphocytes readily and preferentially migrated
on FRC networks in vitro, as has been observed in vivo. Such
techniques are particularly applicable to studies with human
cells.
We found strikingly low variation in stromal cell subsets
between young male age-matched C57Bl/6 mice. In testing
whether cross-talk between lymphocytes and stroma was required
for the expansion of particular stromal subsets, we found that
FRCs, LECs, BECs, and DN stroma were present at normal pro-
portions in Rag−/− mice, showing no requirement for T or B
cells in their development or expansion. TheMRC (MadCAM-1+)
stromal subset has not previously been isolated for ﬂow cytomet-
ric analysis, and we found that MRCs formed a subset within
the podoplanin+ CD31− FRC gate. While MRCs show similar-
ities to FRCs, expressing VCAM-1 and ICAM-1, and secreting
ECM components such as laminin, they additionally produce high
amounts of CXCL13 and can be identiﬁed through expression of
MadCAM-1 (Katakai et al., 2008)
Strikingly, the number of MRCs was signiﬁcantly reduced in
Rag−/− mice. The level of MadCAM protein per cell was also
lower. By histology, MadCAM+ MRCs are visible in skin-draining
Rag−/− lymph nodes (Katakai et al., 2008), however numerical
and quantitative ﬂow cytometric analysis of MadCAM expres-
sion and MRC numbers has not previously been possible. These
data suggest that lymphocytes are indeed required for normal
development of MRCs. Interestingly, LECs from Rag−/− mice
also developed into MadCAM+ cells at reduced proportions, and
showed less protein per cell. It is as yet unclear whether MRCs and
MadCAM+ LECs fail to expand normally in Rag−/− mice, or just
fail to upregulate MadCAM. The role for MadCAM+ LECs is also
undescribed.
Since MRCs show the same phenotype as LTo cells (Katakai
et al., 2008), which construct the lymph node downstream of
lymphotoxin signaling and an NF-κB2 transcription program
(Mebius, 2003;Coles et al., 2010), it has been postulated thatMRCs
may play a role in postnatal maintenance or regeneration of the
lymph node stroma (Katakai et al., 2008). Our results show that
normal expansion and/or maturation of MadCAM+ MRCs is not
required for normal expansion of FRCs, BECs, and DN stroma.
However, further functional studies would be required to deter-
mine if MRC function (expression of chemokines, for example)
and MadCAM expression were inexorably linked.
An unexpected ﬁnding was that the FRCs of skin-draining and
mesenteric lymphnodes signiﬁcantly differed in proportion,num-
ber, and transcriptional proﬁle.We found signiﬁcantly fewer FRCs
in mesenteric lymph nodes, containing reduced expression of sev-
eral important cytokines and chemokines: IL6, IL7, BAFF, CXCL9,
CXCL10, IL1 receptor accessory protein (IL1RAP), Activin recep-
tor IIA, VEGFa, LIF, and cKIT-ligand. Statistically, the pathway
analysis showed that these genes were highly unlikely to have clus-
tered by chance. It will be interesting to determine whether these
changes occur as the result of a congenital developmental differ-
ence, or following exposure to different inﬂammatory cues, such as
differences in antigen exposure frequency or dose. Skin-draining
and mesenteric lymph nodes are exposed to markedly different
microenvironmental stimuli. Unless skin barriers are breached,
FRCs residing in skin-draining lymph nodes from this study could
be expected to encounter large doses of microbe-sourced antigen
relatively rarely. Mesenteric FRCs, however, are constantly exposed
to a barrage of pathogen-associated molecular patterns through
normal functioning of the gut, with important steady-state roles
in Treg induction and oral tolerance (Hadis et al., 2011). These
day-to-day factors are reasonably be expected to alter expression
proﬁle, to unknown effect.
Developmental differences in skin-draining lymph nodes and
mesenteric lymph nodes have been reported: a full comple-
ment of mesenteric lymph nodes are present in Cxcl13−/− and
Cxcr5−/− mice, while many skin-draining lymph nodes are miss-
ing, or develop variably in particular locations (Ansel et al., 2000).
Similarly, Ltb−/− mice develop mesenteric lymph nodes (albeit
abnormally) but lack many skin-draining lymph nodes (Koni
et al., 1997). Since lymph node development is initiated dur-
ing embryogenesis, these results suggest that cytokines capable
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of compensating for CXCL13 or LTβ are more highly available
in prenatal mesenteric lymph nodes than skin-draining lymph
nodes. Similarly, a lower proportion of presumptive lymph node
organizer cells are present in the skin-draining lymph nodes of
neonates compared with mesenteric lymph nodes (Cupedo et al.,
2004). Finally, after transplanting skin-draining lymph nodes to
the mesentery, it was found that MadCAM− BECs do not adopt
the mesenteric MadCAM+ phenotype, suggesting the difference is
developmental andnot a result of exposure to gut-derived antigens
(Ahrendt et al., 2008). A recent study also interestingly suggests
that stroma from transplanted peripheral and mesenteric lymph
nodes may differ in their ability to induce oral tolerance, assum-
ing that carryover hematopoietic cells, progressively replaced by
donor cells after transplant, are not inﬂuential (Buettner et al.,
2011).
In the skin-draining lymph nodes of 6 week old mice, we
found higher expression of several cytokines with known roles
in lymph nodes. IL6, upregulated sixfold in FRCs from skin-
draining lymph nodes, is a cytokine subject to complex regulation.
When produced early in the immune response after exposure to
proinﬂammatory IL1, IL6 is potently immunostimulatory, but
can also exert anti-inﬂammatory functions through dampening
of TNFα and IL1 signaling, and upregulation of IL10. IL10 was
not expressed by stroma (data not shown). Instead, we found>3-
fold upregulation of the IL1 receptor accessory protein (IL1Rap) in
skin-draining lymph nodes, suggesting that skin-draining lymph
node FRCs possess the capacity to increase IL6 production early
in infection. Accordingly, during steady-state, FRCs from skin-
draining lymph nodes also expressed high levels of IL1R1, the
high-afﬁnity binding partner of IL1Rap, and did not express the
decoy analog IL1-RN (Dinarello, 1996; data not shown). Sup-
porting these ﬁndings, we have previously reported that FRCs
respond to TLR3 signaling within hours (Fletcher et al., 2010),
suggesting that FRCs respond swiftly to infection. It is also worth
noting that IL6 is produced in an anti-inﬂammatory capacity
by smooth muscle cells following stretch (Pedersen, 2006), as a
means of phosphorylating PDGF-receptors and stimulating cell
contraction (Hu et al., 1998; Zampetaki et al., 2005). Similarly,
in dermal myoﬁbroblasts, IL6 modulates alpha smooth mus-
cle actin to enhance contraction and wound closure (Gallucci
et al., 2006). Like myoﬁbroblasts, FRCs are highly contractile cells
expressing large amounts of alpha smooth muscle actin (Link
et al., 2007 and data not shown). IL6 shares a receptor with LIF,
which was also upregulated in FRCs from skin-draining lymph
nodes. Like IL6, LIF is upregulated in contracting myocytes as
a means of inducing autocrine or paracrine muscle cell prolif-
eration. IL6, IL1Rap, and LIF represented the three genes most
upregulated by FRCs from skin-draining lymph nodes in the
identiﬁed network.
With direct relevance for lymphocyte function, we found that
IL7 and BAFF were upregulated by more than twofold in skin-
draining FRCs. IL7 is a known product of FRCs, and functions to
maintain naïve T cells (Link et al., 2007). BAFF is a potent survival
factor and costimulatory activator for B cells. In secondary lym-
phoid organs, it is known to be produced by non-hematopoietic
FDCs, but has not previously been reported in FRCs. However,
the expression of BAFF by stromal cells outside lymph nodes is
well-reported, though this seems to require chronic inﬂamma-
tion and has not previously been linked to steady-state stroma
(Mackay and Schneider, 2009). Our cell sorts did not contain FDC
contamination, since during transcriptional analysis, we found
no evidence for expression of Fcγ receptors, and <1% of lymph
node stromal cells stain positive for FDC-M1 or CD35 (data not
shown). FDCs are conﬁned to the B cell follicle, while FRCs sur-
round, and occasionally extend into the B cell follicle. However,
both cell types are thought to develop from a common precursor
(Mebius, 2003). This result supports and extends the list of noted
similarities between these cell types.
Strikingly, our results indicated that CXCL9 and CXCL10 are
expressed by FRCs in skin-draining and mesenteric lymph nodes.
These chemokines both signal through CXCR3, expressed by acti-
vated T cells, B cells, and NK cells, and their transcription is
upregulated by IFNγ, IFNα, and other proinﬂammatory stim-
uli (Muller et al., 2010). While a role for CXCL10 in lymph
nodes during steady-state has not been described, during some
infections CXCL10 has an important role retaining Th1 lym-
phocytes in lymph nodes, a mechanism which encourages newly
activated T cells to also becomeTh1, creating a polarized,microbe-
appropriate response (Yoneyama et al., 2002). However, to date,
CXCL10 production has only been identiﬁed in mature DCs
within lymph nodes (Yoneyama et al., 2002). These data show
that CXCL10 mRNA is also expressed by steady-state FRCs, with
unknown function.
CXCL9 is poorly studied, but has been observed in DCs from
cancer-associated lymphoid tissues and draining lymph nodes
(Ohtani et al., 2009), any role in steady-state regulation of cell
migration in lymph nodes is unreported.
Interestingly, FRCs from both mesenteric and skin-draining
lymph nodes expressed genes involved in signaling to endothe-
lial cells. It is known that FRCs are the primary producers of
VEGF in skin-draining lymph nodes under steady-state condi-
tions (Chyou et al., 2008). Surprisingly we found that FRCs from
skin-draining lymph nodes expressed higher levels of VEGFa than
those from mesenteric lymph nodes. Indeed, mesenteric lymph
nodes showed upregulation of a relatively short list of genes com-
pared to skin-draining lymph nodes, and the results did not map
to a functional pathway when our robust statistical correction for
multiple hypotheses was performed. However,we observed upreg-
ulation of known gut-related genes such as Nkx2-3, required for
MadCAM expression and lymphocyte segregation in mesenteric
lymph nodes (Pabst et al., 2000); as well as upregulation of Lrat,
Tgm2, Meis1, and Pltp. These genes are either involved in the
retinoic acid metabolism cycle, or upregulated by retinoic acid,
(Matsuura and Ross, 1993; Cao et al., 2002; Galdones et al., 2006;
Rebe et al., 2009) which is processed in mesenteric lymph nodes to
impose a gut-speciﬁc homing phenotype on T cells (Iwata, 2009).
We also found expression of several vasodilators (Vipr2, Itih4,
Npr1) and a vasoconstrictor (Agt) suggesting that FRCs actively
communicate with lymph node blood vessels. Similarly, upreg-
ulation of genes that induce neurite outgrowth (Efna5, gpr126,
Tmem35, and Ngf) suggests a potential role in maintaining the
normal sympathetic innervation of the lymph node (Panuncio
et al., 1999). Further studies would be required to validate these
results.
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Taken together, altered expression of cytokines and chemokines
in skin-draining lymph nodes suggests a novel picture of microen-
vironmental regulation by FRCs. Expression of BAFF and CXCR3
ligands imply previously unreported mechanisms of cross-talk
with the hematopoietic system. Similarly, the upregulation of
IL6, IL1Rap, and LIF suggests that skin-draining lymph node
FRCs may be more contractile, and/or actively dividing faster
than their mesenteric lymph node counterparts, similarly inﬂu-
encing endothelial cells to keep pace by transcribing increased
VEGFα.
These transcriptional events may not be occurring equally
across all FRCs,however. Lymphnodes contain anumber of poorly
understood FRC microniches. The best studied of these is the cor-
tical T cell zone FRC, (sometimes called a TRC), which produces
IL7, CCL19, CCL21, maintains the conduit system, and is used as
a scaffold for the migration of DCs, T cells, and B cells. However,
ﬁbroblastic gp38+CD31− cells exist throughout the lymph node:
in the subcapsular region abutting B cell follicles; as pericytes;
and throughout the medulla. It is not yet possible to differentiate
between these different FRC types, and the differences between
skin-draining lymph nodes and mesenteric lymph nodes may
involve a change in their proportion, if they differentially express
the cytokines and chemokines identiﬁed.
Together, these data represent a comprehensive catalog of
techniques adapted for lymph node stromal cells.
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